Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Langer

Showing results (501-510 of 517) with videos related to

Pageof 52
Sort By:
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.
Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.
Journal of the American College of Cardiology|July 14, 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-upK P Alexander, L K Newby, A S Hellkamp, et al.
The American Journal of Cardiology|August 29, 2001
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor, W A Gattis, A S Hellkamp, et al.
Behavior Therapy|June 27, 2024
Reckoning With Our Past and Righting Our Future: Report From the Behavior Therapy Task Force on Sexual Orientation and Gender Identity/Expression Change Efforts (SOGIECEs)Jonathan S Comer, Christopher Georgiadis, Katie Schmarder, et al.
Epidemiology and Infection|May 1, 2010
Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: a study incorporating epidemiological and food source traceback resultsS V Sodha, M Lynch, K Wannemuehler, et al.
Lancet (London, England)|May 30, 2001
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal careJ Villar, H Ba'aqeel, G Piaggio, et al.
Archives of General Psychiatry|November 9, 2011
Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trialJohn R Weisz, Bruce F Chorpita, Lawrence A Palinkas, et al.
Pageof 52

Showing results (501-510 of 517) with videos related to

Sort By:
Pageof 52
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.
Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.
Journal of the American College of Cardiology|July 14, 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-upK P Alexander, L K Newby, A S Hellkamp, et al.
The American Journal of Cardiology|August 29, 2001
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor, W A Gattis, A S Hellkamp, et al.
Behavior Therapy|June 27, 2024
Reckoning With Our Past and Righting Our Future: Report From the Behavior Therapy Task Force on Sexual Orientation and Gender Identity/Expression Change Efforts (SOGIECEs)Jonathan S Comer, Christopher Georgiadis, Katie Schmarder, et al.
Epidemiology and Infection|May 1, 2010
Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: a study incorporating epidemiological and food source traceback resultsS V Sodha, M Lynch, K Wannemuehler, et al.
Lancet (London, England)|May 30, 2001
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal careJ Villar, H Ba'aqeel, G Piaggio, et al.
Archives of General Psychiatry|November 9, 2011
Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trialJohn R Weisz, Bruce F Chorpita, Lawrence A Palinkas, et al.
Pageof 52